{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T17:04:18Z","timestamp":1773421458892,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Cardiol"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s00246-019-02273-2","type":"journal-article","created":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T06:02:45Z","timestamp":1578376965000},"page":"398-406","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Management of Persistent Pulmonary Hypertension After Correction of Congenital Heart Defect with Autologous Marrow-Derived Mononuclear Stem Cell Injection into the Pulmonary Artery: A Pilot Study"],"prefix":"10.1007","volume":"41","clinical-trial-number":[{"clinical-trial-number":"irct2017080435442n1","registry":"10.18810\/irct"}],"author":[{"given":"Hamid","family":"Amoozgar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pegah","family":"Banafi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6606-2795","authenticated-orcid":false,"given":"Hamid","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Reza","family":"Edraki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nima","family":"Mehdizadegan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gholamhossein","family":"Ajami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Borzouee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kambiz","family":"Keshaarz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Poria","family":"Moradi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elham","family":"Dehghani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,7]]},"reference":[{"issue":"11","key":"2273_CR1","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1093\/eurheartj\/eht437","volume":"35","author":"K Dimopoulos","year":"2013","unstructured":"Dimopoulos K, Wort SJ, Gatzoulis MA (2013) Pulmonary hypertension related to congenital heart disease: a call for action. Eur Heart J 35(11):691\u2013700. https:\/\/doi.org\/10.1093\/eurheartj\/eht437","journal-title":"Eur Heart J"},{"issue":"14","key":"2273_CR2","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1136\/heartjnl-2017-312143","volume":"104","author":"N Skoro-Sajer","year":"2018","unstructured":"Skoro-Sajer N, Gerges C, Balint OH, Kohalmi D, Kaldararova M, Simkova I, Jakowitsch J, Gabriel H, Baumgartner H, Gerges M, Sadushi-Kolici R, Celermajer DS, Lang IM (2018) Subcutaneous treprostinil in congenital heart disease-related pulmonary arterial hypertension. Heart 104(14):1195\u20131199. https:\/\/doi.org\/10.1136\/heartjnl-2017-312143","journal-title":"Heart"},{"issue":"4","key":"2273_CR3","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.jpeds.2010.06.010","volume":"157","author":"C Tissot","year":"2010","unstructured":"Tissot C, Ivy DD, Beghetti M (2010) Medical therapy for pediatric pulmonary arterial hypertension. J Pediatr 157(4):528\u2013532. https:\/\/doi.org\/10.1016\/j.jpeds.2010.06.010","journal-title":"J Pediatr"},{"issue":"1","key":"2273_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/cce2.74","volume":"4","author":"AA Frogoudaki","year":"2018","unstructured":"Frogoudaki AA, Gatzoulis MA (2018) Pulmonary arterial hypertension in congenital heart disease. Contin Cardiol Educ 4(1):23\u201333. https:\/\/doi.org\/10.1002\/cce2.74","journal-title":"Contin Cardiol Educ"},{"key":"2273_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/9781444311846.ch5","author":"K Owusu-Ansah","year":"2009","unstructured":"Owusu-Ansah K, Lim Z, Veldtman GR (2009) Pulmonary arterial hypertension in Eisenmenger syndrome. Adult Congenit Heart Dis. 4(1):23\u201333. https:\/\/doi.org\/10.1002\/9781444311846.ch5","journal-title":"Adult Congenit Heart Dis."},{"issue":"126","key":"2273_CR6","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1183\/09059180.00004712","volume":"21","author":"M D'Alto","year":"2012","unstructured":"D'Alto M, Mahadevan VS (2012) Pulmonary arterial hypertension associated with congenital heart disease. Eur Respir Rev 21(126):328\u2013337. https:\/\/doi.org\/10.1183\/09059180.00004712","journal-title":"Eur Respir Rev"},{"issue":"14","key":"2273_CR7","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1056\/nejmra040291","volume":"351","author":"M Humbert","year":"2004","unstructured":"Humbert M, Sitbon O, Simonneau G (2004) Treatment of pulmonary arterial hypertension. N Engl J Med 351(14):1425\u20131436. https:\/\/doi.org\/10.1056\/nejmra040291","journal-title":"N Engl J Med"},{"issue":"11","key":"2273_CR8","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1002\/ajh.24174","volume":"90","author":"NP Shah","year":"2015","unstructured":"Shah NP, Wallis N, Farber HW, Mauro MJ, Wolf RA, Mattei D, Guha M, Rea D, Peacock A (2015) Clinical features of pulmonary arterial hypertension in patients receiving dasatinib. Am J Hematol 90(11):1060\u20131064. https:\/\/doi.org\/10.1002\/ajh.24174","journal-title":"Am J Hematol"},{"issue":"11","key":"2273_CR9","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1093\/eurheartj\/eht072","volume":"35","author":"A Manes","year":"2013","unstructured":"Manes A, Palazzini M, Leci E, Bacchi Reggiani ML, Branzi A, Galie N (2013) Current era survival of patients with pulmonary arterial hypertension associated with congenital heart disease: a comparison between clinical subgroups. Eur Heart J 35(11):716\u2013724. https:\/\/doi.org\/10.1093\/eurheartj\/eht072","journal-title":"Eur Heart J"},{"issue":"9","key":"2273_CR10","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.jacc.2008.11.025","volume":"53","author":"M Beghetti","year":"2009","unstructured":"Beghetti M, Gali\u00e8 N (2009) Eisenmenger syndrome. J Am Coll Cardiol 53(9):733\u2013740. https:\/\/doi.org\/10.1016\/j.jacc.2008.11.025","journal-title":"J Am Coll Cardiol"},{"key":"2273_CR11","doi-asserted-by":"crossref","unstructured":"de Jesus Perez V (2017) Faculty of 1000 evaluation for 2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). F1000-Post-publication peer review of the biomedical literature. F1000 (Faculty of 1000 Ltd). doi:10.3410\/f.725758087.793519769","DOI":"10.3410\/f.725758087.793519769"},{"issue":"4","key":"2273_CR12","doi-asserted-by":"publisher","first-page":"S241","DOI":"10.1016\/j.healun.2018.01.597","volume":"37","author":"S Hascoet","year":"2018","unstructured":"Hascoet S, Pontailler M, Mercier O, Fabre D, Mussot S, Humbert M, Simonneau G, Jais X, Sitbon O, Fadel E (2018) Outcome of heart-lung or double-lung transplantation in pulmonary hypertension secondary to congenital heart diseases. J Heart Lung Transplant 37(4):S241. https:\/\/doi.org\/10.1016\/j.healun.2018.01.597","journal-title":"J Heart Lung Transplant"},{"issue":"3","key":"2273_CR13","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1634\/stemcells.22-3-377","volume":"22","author":"J Oswald","year":"2004","unstructured":"Oswald J, Boxberger S, J\u00f8rgensen B, Feldmann S, Ehninger G, Bornh\u00e4user M, Werner C (2004) Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells 22(3):377\u2013384. https:\/\/doi.org\/10.1634\/stemcells.22-3-377","journal-title":"Stem Cells"},{"issue":"6","key":"2273_CR14","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1161\/01.atv.0000165696.25680.ce","volume":"25","author":"R Matsumoto","year":"2005","unstructured":"Matsumoto R, Omura T, Yoshiyama M, Hayashi T, Inamoto S, Koh K-R, Ohta K, Izumi Y, Nakamura Y, Akioka K, Kitaura Y, Takeuchi K, Yoshikawa J (2005) Vascular endothelial growth factor-expressing mesenchymal stem cell transplantation for the treatment of acute myocardial infarction. Arterioscler Thromb Vasc Biol 25(6):1168\u20131173. https:\/\/doi.org\/10.1161\/01.atv.0000165696.25680.ce","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"2273_CR15","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1042\/cbi20110016","volume":"35","author":"M Ayatollahi","year":"2011","unstructured":"Ayatollahi M, Soleimani M, Geramizadeh B, Imanieh MH (2011) Insulin-like growth factor 1 (IGF-I) improves hepatic differentiation of human bone marrow-derived mesenchymal stem cells. Cell Biol Int 35(11):1169\u20131176. https:\/\/doi.org\/10.1042\/cbi20110016","journal-title":"Cell Biol Int"},{"key":"2273_CR16","doi-asserted-by":"publisher","first-page":"S153","DOI":"10.1097\/01.wox.0000411598.12314.d1","volume":"5","author":"M Ayatollahi","year":"2012","unstructured":"Ayatollahi M, Zarifi F, Zakerinia M, Rezvani A, Ramzi M (2012) 483 immunomodulatory effects of human bone marrow-derived mesenchymal stem cells. World Allergy Organ J 5:S153\u2013S154. https:\/\/doi.org\/10.1097\/01.wox.0000411598.12314.d1","journal-title":"World Allergy Organ J"},{"issue":"3","key":"2273_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5812\/ijp.83408","volume":"29","author":"H Amoozgar","year":"2019","unstructured":"Amoozgar H, Edraki MR, Ayatollahi M, Borzouee M, Ajami G, Mohammadi H, Mehdizadegan N, Shakibazad N, Arabi H, Alwesabi F (2019) A study of intracoronary injection of hematopoietic stem cells in pediatric dilated cardiomyopathy: is it an applicable solution for critically Ill patients? Iran J Pediatr 29(3)","journal-title":"Iran J Pediatr"},{"issue":"5","key":"2273_CR18","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/hr.2012.217","volume":"36","author":"L Wei","year":"2013","unstructured":"Wei L, Zhu W, Xia L, Yang Y, Liu H, Shen J, Zhu J, Xu Y, Yang Z, Wang C (2013) Therapeutic effect of eNOS-transfected endothelial progenitor cells on hemodynamic pulmonary arterial hypertension. Hypertens Res 36(5):414\u2013421. https:\/\/doi.org\/10.1038\/hr.2012.217","journal-title":"Hypertens Res"},{"key":"2273_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01395","author":"AKN Alencar","year":"2018","unstructured":"Alencar AKN, Pimentel-Coelho PM, Montes GC, da Silva MdMC, Mendes LVP, Montagnoli TL, Silva AMS, Vasques JF, Rosado-de-Castro PH, Gutfilen B, Cunha VdMN, Fraga AGM, Silva PMRe, Martins MA, Ferreira TPT, Mendes-Otero R, Trachez MM, Sudo RT, Zapata-Sudo G, (2018) Human mesenchymal stem cell therapy reverses Su5416\/hypoxia-induced pulmonary arterial hypertension in mice. Front Pharmacol 9: https:\/\/doi.org\/10.3389\/fphar.2018.01395","journal-title":"Front Pharmacol"},{"issue":"3","key":"2273_CR20","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.jtcvs.2015.05.035","volume":"150","author":"G Cao","year":"2015","unstructured":"Cao G, Liu C, Wan Z, Liu K, Sun H, Sun X, Tang M, Bing W, Wu S, Pang X, Zhang X (2015) Combined hypoxia inducible factor-1\u03b1 and homogeneous endothelial progenitor cell therapy attenuates shunt flow-induced pulmonary arterial hypertension in rabbits. J Thorac Cardiovasc Surg 150(3):621\u2013632. https:\/\/doi.org\/10.1016\/j.jtcvs.2015.05.035","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"2273_CR21","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1186\/s13287-017-0669-0","volume":"8","author":"L de Mendon\u00e7a","year":"2017","unstructured":"de Mendon\u00e7a L, Felix NS, Blanco NG, Da Silva JS, Ferreira TP, Abreu SC, Cruz FF, Rocha N, Silva PM, Martins V, Capelozzi VL, Zapata-Sudo G, Rocco PRM, Silva PL (2017) Mesenchymal stromal cell therapy reduces lung inflammation and vascular remodeling and improves hemodynamics in experimental pulmonary arterial hypertension. Stem Cell Res Therapy 8(1):621\u2013632. https:\/\/doi.org\/10.1186\/s13287-017-0669-0","journal-title":"Stem Cell Res Therapy"},{"issue":"6","key":"2273_CR22","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1089\/scd.2010.0222","volume":"20","author":"K Liu","year":"2011","unstructured":"Liu K, Liu R, Cao G, Sun H, Wang X, Wu S (2011) Adipose-derived stromal cell autologous transplantation ameliorates pulmonary arterial hypertension induced by shunt flow in rat models. Stem Cells Dev 20(6):1001\u20131010. https:\/\/doi.org\/10.1089\/scd.2010.0222","journal-title":"Stem Cells Dev"},{"issue":"14","key":"2273_CR23","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1016\/j.jacc.2006.12.037","volume":"49","author":"X-X Wang","year":"2007","unstructured":"Wang X-X, Zhang F-R, Shang Y-P, Zhu J-H, Xie X-D, Tao Q-M, Zhu J-H, Chen J-Z (2007) Transplantation of autologous endothelial progenitor cells may be beneficial in patients with idiopathic pulmonary arterial hypertension. J Am Coll Cardiol 49(14):1566\u20131571. https:\/\/doi.org\/10.1016\/j.jacc.2006.12.037","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"2273_CR24","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1161\/circresaha.114.305951","volume":"117","author":"J Granton","year":"2015","unstructured":"Granton J, Langleben D, Kutryk MB, Camack N, Galipeau J, Courtman DW, Stewart DJ (2015) Endothelial NO-synthase gene-enhanced progenitor cell therapy for pulmonary arterial hypertension. Circ Res 117(7):645\u2013654. https:\/\/doi.org\/10.1161\/circresaha.114.305951","journal-title":"Circ Res"},{"issue":"6","key":"2273_CR25","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1111\/j.1399-3046.2007.00863.x","volume":"12","author":"JH Zhu","year":"2008","unstructured":"Zhu JH, Wang XX, Zhang FR, Shang YP, Tao QM, Zhu JH, Chen JZ (2008) Safety and efficacy of autologous endothelial progenitor cells transplantation in children with idiopathic pulmonary arterial hypertension: open-label pilot study. Pediatr Transplant 12(6):650\u2013655. https:\/\/doi.org\/10.1111\/j.1399-3046.2007.00863.x","journal-title":"Pediatr Transplant"},{"issue":"3","key":"2273_CR26","first-page":"38","volume":"1","author":"A Lacis","year":"2014","unstructured":"Lacis A, Lacis A, Lubaua I, Erglis A (2014) Stem cell therapy as one of temporary measures for management of heart failure and pulmonary hypertension in children. Am J Exp Clin Res 1(3):38\u201346","journal-title":"Am J Exp Clin Res"},{"key":"2273_CR27","doi-asserted-by":"publisher","DOI":"10.17265\/1548\u20136648\/2013.02.002","author":"L Aris","year":"2013","unstructured":"Aris L, Inguna L, Inta B, Eriks J, Janis A, Andis L, Andrejs E (2013) Safeguards and pitfalls in technique used for stem cell delivery in children suffering from idiopathic dilated cardiomyopathy. J US-China Med Sci 10 (2). doi:10.17265\/1548\u20136648\/2013.02.002","journal-title":"J US-China Med Sci"}],"container-title":["Pediatric Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-019-02273-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00246-019-02273-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-019-02273-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T13:51:44Z","timestamp":1628603504000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00246-019-02273-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,7]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["2273"],"URL":"https:\/\/doi.org\/10.1007\/s00246-019-02273-2","relation":{},"ISSN":["0172-0643","1432-1971"],"issn-type":[{"value":"0172-0643","type":"print"},{"value":"1432-1971","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,7]]},"assertion":[{"value":"19 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee of Shiraz University of Medical Sciences with the code of 95-01-01-12150 and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was also registered in the Iranian Registry of Clinical Trials (code of IRCT2017080435442N1).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Written informed consent was taken from each patient or his\/her guardian.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}